Related Experiment Video
Updated: Nov 10, 2025

07:51
Pull-down of Calmodulin-binding Proteins
Published on: January 23, 2012
25.6K
Calmodulin and Its Binding Proteins in Parkinson's Disease
Anastasiia Bohush1, Wiesława Leśniak1, Serge Weis2
1Nencki Institute of Experimental Biology, Polish Academy of Sciences, 3 Pasteur Street, 02-093 Warsaw, Poland.
International Journal of Molecular Sciences
|April 3, 2021
Summary
Calmodulin, a calcium sensor, and its associated proteins are crucial for neuronal function. Dysregulation of these proteins may contribute to the development and progression of Parkinson's disease (PD).
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor symptoms and loss of dopaminergic neurons.
- Calcium (Ca2+) signaling is vital for neuronal function, and disruptions in Ca2+ homeostasis can lead to cell death.
- Dopaminergic neurons are particularly vulnerable to alterations in intracellular Ca2+ levels.
Purpose of the Study:
- To review the current literature on the role of calmodulin and its binding proteins in Parkinson's disease.
- To explore the connection between Ca2+ signaling, calmodulin, and PD pathogenesis.
- To highlight potential therapeutic targets related to calmodulin in PD.
Main Methods:
- Literature review of published studies on calmodulin, Ca2+ signaling, and Parkinson's disease.
- Analysis of research investigating the function of calmodulin-binding proteins in neuronal health and disease.
- Synthesis of findings related to the involvement of these pathways in PD pathology.
Main Results:
- Calmodulin is a key Ca2+ sensor regulating numerous cellular processes in neurons.
- Calmodulin and its binding proteins are essential for synaptic function and neuronal plasticity.
- Alterations in calmodulin activity and its downstream targets are implicated in the neurodegenerative processes observed in PD.
Conclusions:
- Calmodulin and its associated proteins play a significant role in the pathology and pathogenesis of Parkinson's disease.
- Understanding the intricate involvement of Ca2+ signaling and calmodulin pathways offers insights into PD mechanisms.
- Further research into calmodulin-dependent pathways may reveal novel therapeutic strategies for Parkinson's disease.
Keywords:
Ca2+ homeostasisCa2+- signalingParkinson’s diseasecalcineurincalmodulincalmodulin binding proteinscalmodulin kinase IIMore Related Videos
Related Concept Videos
Calmodulin-dependent Signaling
5.5K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.5K
Parkinson's Disease: Treatment
702
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
702
Parkinson's Disease: Overview
1.1K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.1K
Neural Regulation
41.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
41.2K
Microtubule Associated Proteins (MAPs)
5.2K
Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
5.2K
Protein Kinases and Phosphatases
14.1K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
14.1K

